Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Liver    crawled date : 2021 - 07 - 01    save search

Verra Mobility Partners with Eurowag to Enable Delivery of Interoperable Toll Payment Solutions in Europe
Published: 2021-07-01 (Crawled : 23:00) - verramobility.com
VRRM | $23.7 -1.58% -1.6% 570K twitter stocktwits trandingview |
Transportation
| | O: 0.06% H: 1.88% C: 1.42%

europe liver
Distinction is for Cisco Channel Partners capable of delivering industry-leading IoT solutions to customers
Published: 2021-07-01 (Crawled : 22:00) - prnewswire.com
FITB | $34.08 -0.03% -0.03% 5.5M twitter stocktwits trandingview |
Finance
| | O: 0.26% H: 0.08% C: -1.03%

iot liver
Future Market Insights' 250 Pages Ocular Drug Delivery System Market Study Identifies Demand for Targeted Techniques for Ophthalmic Disease Treatment, a Chief Growth Driver
Published: 2021-07-01 (Crawled : 14:15) - prnewswire.com
OCUL | $7.58 -2.7% -2.77% 980K twitter stocktwits trandingview |
Health Technology
| | O: -0.07% H: 1.83% C: 1.2%

disease treatment ocular drug growth drug delivery liver
GSE Solutions to Deliver Simulation Solution for Global Energy Utility Based in Saudi Arabia
Published: 2021-07-01 (Crawled : 13:00) - prnewswire.com
GVP | $2.47 -1.98% -2.02% 6.1K twitter stocktwits trandingview |
Commercial Services
| | O: 1.12% H: 0.0% C: -9.39%

energy liver
Pressure BioSciences Novel UST Platform Delivers Breakthrough Nanoemulsion Processing for One of the World's Most Potent Antioxidants - Astaxanthin
Published: 2021-07-01 (Crawled : 13:00) - biospace.com/
PBIO | $0.25 88.01% 43K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 14.29% C: 11.52%

liver
Novocure Presents Final Safety and Efficacy Results from its Phase 2 Pilot HEPANOVA Trial in Liver Cancer
Published: 2021-07-01 (Crawled : 12:00) - biospace.com/
NVCR | $12.04 -3.37% -3.49% 1.4M twitter stocktwits trandingview |
Health Technology
| | O: -6.82% H: 0.38% C: -8.21%

phase 2 results cancer liver trial
NIO Inc. Provides June and Second Quarter 2021 Delivery Update
Published: 2021-07-01 (Crawled : 09:00) - globenewswire.com
NIO | $3.91 2.63% -0.26% 39M twitter stocktwits trandingview |
Consumer Durables
| | O: 2.95% H: 0.66% C: -7.07%

liver
Gainers vs Losers
56% 44%

Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M twitter stocktwits trandingview |
Health Technology

SINT | $0.0365 59.39% 37.26% 470M twitter stocktwits trandingview |
Health Technology

WISA 4 | $9.19 50.66% 33.7% 65M twitter stocktwits trandingview |
Electronic Technology

EDBL | News | $6.73 47.91% 32.39% 13M twitter stocktwits trandingview |

GCTK | $0.715 36.27% 26.62% 640K twitter stocktwits trandingview |
Manufacturing

TCON | $2.33 36.26% 26.61% 2M twitter stocktwits trandingview |
Health Technology

TIRX | $0.48 6.43% 24.58% 4.8M twitter stocktwits trandingview |

KZIA | $0.38 30.58% 23.42% 300K twitter stocktwits trandingview |
Health Technology

VNDA | News | $5.23 29.14% 22.56% 24M twitter stocktwits trandingview |
Health Technology

ATNF | $1.91 29.05% 22.51% 310K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.